DiaMonTech unveils non-invasive method for measuring blood glucose levels

By Jonathan Dyble
German healthcare firm DiaMonTech has unveiled a new breakthrough technology with its non-invasive method for measuring the body’s blood glucose level...

German healthcare firm DiaMonTech has unveiled a new breakthrough technology with its non-invasive method for measuring the body’s blood glucose levels.

In a timely manner, the new announcement was made on world diabetes day – a condition that will be revolutionised by the new technology by removing the need for finger pricking in order to measure glucose levels.

See also:

“With 400 million people suffering from diabetes worldwide, this new device will liberate many from the antiquated means of pricking their fingers and the potential health risks it carries,” DiaMonTech said.

DiaMonTech’s Head of Research and Development and Director of the Biophysics Institute at Goethe University, Professor Werner Mäntele, was behind its development – a man who specialises in spectroscopy and molecule detection.

“Unlike previous diabetic monitoring methods, which have focused on one particular layer of the skin to measure blood glucose, DiaMonTech’s approach means blood glucose is measured with ‘depth-profiling’,” Mäntele said.

“This method allows us to measure one’s skin at a multitude of different depths and is fine-tuned to measure glucose molecules rather than a high-level overview.” 

A DiaMonTech desktop device is scheduled for release in 2018, with smaller pocket-sized devices to come in 2019 and a smart-wristband that constantly monitors glucose levels expected in 2021.

Share

Featured Articles

WHO Health Chatbot Built on 'Humanised' GenAI

World Health Organisation's GenAI digital health tool is built using ‘AI humanisation’ tech & designed to ease burden on health workers & educate on health

Costco Weight-Loss Drugs Move Highlights US AOM Growth

Costco move to partner with online healthcare provider Sesame to provide members with weight-loss drugs including Wegovy signals US anti-obesity boom

AstraZeneca Company Profile, as CEO Soriot Lands pay Deal

As it's announced AstraZeneca's CEO Pascal Soriot's package could rise by as much as US$24mn we explore the history of the UK's most valuable business

US Academic Medical Centres 'Struggling' says McKinsey

Hospitals

J&J Community Initiatives Tackle US Healthcare Chasm

Medical Devices & Pharma

PitchBook: Healthcare Private Equity Deals see Decline

Health Insurance & Finance